Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Prasad

Showing results (331-340 of 338) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 338 results.
Nature Communications|April 25, 2015
DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesisRajneesh Pathania, Sabarish Ramachandran, Selvakumar Elangovan, et al.
Molecular Cancer Research : MCR|June 8, 2021
RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to ChemotherapyAllison E Bridges, Sabarish Ramachandran, Kavin Tamizhmani, et al.
Nature Genetics|December 2, 1999
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13)W T McGuirt, S D Prasad, A J Griffith, et al.
Human Vaccines & Immunotherapeutics|November 15, 2023
Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infantsKrishna Kumari P, Siddharth Reddy Chiteti, Vinay K Aileni, et al.
Iscience|March 16, 2021
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluationBrunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, et al.
Iscience|February 1, 2021
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster modelSreelekshmy Mohandas, Pragya D Yadav, Anita Shete-Aich, et al.
The Lancet. Respiratory Medicine|March 1, 2026
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trialAnne E Holland, Mariana Hoffman, Tamera J Corte, et al.
The Medical Journal of Australia|February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summaryHelen E Jo, Jyotika D Prasad, Lauren K Troy, et al.
Pageof 34

Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
Nature Communications|April 25, 2015
DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesisRajneesh Pathania, Sabarish Ramachandran, Selvakumar Elangovan, et al.
Molecular Cancer Research : MCR|June 8, 2021
RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to ChemotherapyAllison E Bridges, Sabarish Ramachandran, Kavin Tamizhmani, et al.
Nature Genetics|December 2, 1999
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13)W T McGuirt, S D Prasad, A J Griffith, et al.
Human Vaccines & Immunotherapeutics|November 15, 2023
Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infantsKrishna Kumari P, Siddharth Reddy Chiteti, Vinay K Aileni, et al.
Iscience|March 16, 2021
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluationBrunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, et al.
Iscience|February 1, 2021
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster modelSreelekshmy Mohandas, Pragya D Yadav, Anita Shete-Aich, et al.
The Lancet. Respiratory Medicine|March 1, 2026
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trialAnne E Holland, Mariana Hoffman, Tamera J Corte, et al.
The Medical Journal of Australia|February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summaryHelen E Jo, Jyotika D Prasad, Lauren K Troy, et al.
Pageof 34